The Epidemiology of Migraine Headache in Arab Countries: A Systematic Review.
Journal
TheScientificWorldJournal
ISSN: 1537-744X
Titre abrégé: ScientificWorldJournal
Pays: United States
ID NLM: 101131163
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
01
2020
accepted:
08
05
2020
entrez:
2
7
2020
pubmed:
2
7
2020
medline:
4
6
2021
Statut:
epublish
Résumé
Recurring migraine disorders are a common medical problem, standing among the top causes of disability and sufferings. This study aimed to evaluate epidemiological evidence to report updated estimates on prevalence, risk factors, and associated comorbidities of migraine headache in the Arab countries. A systematic search in electronic databases, such as PubMed and Embase, as well as manual searches with cross-referencing was performed from 1990 up to 2019. Overall, 23 included papers were rated independently by two reviewers. Studies were eligible for inclusion only if they investigated migraine headache epidemiology in any Arab country and were published in English. Migraine prevalence among the general population ranged between 2.6% and 32%. The estimated prevalence of migraine headache among medical university students ranged between 12.2% and 27.9% and between 7.1% and 13.7% in schoolchildren (6 to 18 years). Females were found more likely to have migraine than males. The duration of migraine attacks became shorter with increasing age, while chronic (daily) migraine showed increasing prevalence with age. The most commonly reported comorbidities with migraine included anxiety, hypertension, irritable bowel syndrome, and depression. Most common headache-triggering factors included stress, fatigue, sleep disturbances, prolonged exposure to excessive sunlight or heat, and hunger. The prevalence and risk factors of migraine headache in Arab countries are comparable to reports from western countries. Longitudinal studies are still needed to investigate the prognosis and predictors of chronicity in the arab countries.
Sections du résumé
BACKGROUND
BACKGROUND
Recurring migraine disorders are a common medical problem, standing among the top causes of disability and sufferings. This study aimed to evaluate epidemiological evidence to report updated estimates on prevalence, risk factors, and associated comorbidities of migraine headache in the Arab countries.
METHODS
METHODS
A systematic search in electronic databases, such as PubMed and Embase, as well as manual searches with cross-referencing was performed from 1990 up to 2019. Overall, 23 included papers were rated independently by two reviewers. Studies were eligible for inclusion only if they investigated migraine headache epidemiology in any Arab country and were published in English.
RESULTS
RESULTS
Migraine prevalence among the general population ranged between 2.6% and 32%. The estimated prevalence of migraine headache among medical university students ranged between 12.2% and 27.9% and between 7.1% and 13.7% in schoolchildren (6 to 18 years). Females were found more likely to have migraine than males. The duration of migraine attacks became shorter with increasing age, while chronic (daily) migraine showed increasing prevalence with age. The most commonly reported comorbidities with migraine included anxiety, hypertension, irritable bowel syndrome, and depression. Most common headache-triggering factors included stress, fatigue, sleep disturbances, prolonged exposure to excessive sunlight or heat, and hunger.
CONCLUSION
CONCLUSIONS
The prevalence and risk factors of migraine headache in Arab countries are comparable to reports from western countries. Longitudinal studies are still needed to investigate the prognosis and predictors of chronicity in the arab countries.
Identifiants
pubmed: 32607079
doi: 10.1155/2020/4790254
pmc: PMC7315321
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4790254Informations de copyright
Copyright © 2020 Ashraf El-Metwally et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Neurol Sci. 2011 May;32 Suppl 1:S85-8
pubmed: 21533720
Headache. 2006 Oct;46(9):1334-43
pubmed: 17040331
Neuropsychiatr Dis Treat. 2013;9:1295-300
pubmed: 24043938
Saudi Med J. 2004 Dec;25(12):1849-54
pubmed: 15711653
J Clin Med Res. 2018 Feb;10(2):125-133
pubmed: 29317957
Neurol Res. 2016 Mar;38(3):232-41
pubmed: 27078706
Headache. 2014 Apr;54(4):610-8
pubmed: 24666014
PLoS One. 2014 Nov 07;9(11):e111123
pubmed: 25379668
J Clin Epidemiol. 1995 Feb;48(2):269-80
pubmed: 7869073
Neuroepidemiology. 1997;16(1):48-52
pubmed: 8994940
Neurology. 2001;56(6 Suppl 1):S4-12
pubmed: 11294954
Cephalalgia. 2001 Sep;21(7):774-7
pubmed: 11595011
Headache. 2002 Apr;42(4):281-6
pubmed: 12010385
BMC Neurol. 2018 Jul 2;18(1):95
pubmed: 29966529
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Saudi Med J. 2005 Apr;26(4):566-70
pubmed: 15900361
Neuroepidemiology. 1993;12(5):285-99
pubmed: 8309504
J Headache Pain. 2009 Aug;10(4):265-70
pubmed: 19387792
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
PLoS One. 2012;7(9):e45295
pubmed: 23024814
Headache. 2004 Jan;44(1):8-19
pubmed: 14979878
J Headache Pain. 2015;16:85
pubmed: 26438329
Int J Epidemiol. 2003 Dec;32(6):1078-80
pubmed: 14681278
Biomed Res Int. 2015;2015:173165
pubmed: 25695049
Headache. 1990 May;30(6):359-62
pubmed: 2370138
J Neurosci. 2015 Apr 29;35(17):6619-29
pubmed: 25926442
J Clin Neurol. 2012 Sep;8(3):204-11
pubmed: 23091530
Headache. 2011 Jun;51(6):860-8
pubmed: 21592096
Neurology. 2001 Feb 13;56(3):350-4
pubmed: 11171900
Curr Neurol Neurosci Rep. 2015 Mar;15(3):5
pubmed: 25652090
J Neurol Sci. 2017 Jan 15;372:307-315
pubmed: 28017235
Headache. 1996 Jun;36(6):385-8
pubmed: 8707558
Maturitas. 2017 Mar;97:28-31
pubmed: 28159058
Pak J Med Sci. 2017 Mar-Apr;33(2):270-275
pubmed: 28523020
Ann Saudi Med. 1998 Nov-Dec;18(6):522-4
pubmed: 17344729
J Headache Pain. 2014 May 10;15:26
pubmed: 24886258
Saudi Med J. 2009 Jan;30(1):120-4
pubmed: 19139785
Headache. 2015 Mar;55(3):359-80
pubmed: 25754865
Cephalalgia. 2011 May;31(7):837-50
pubmed: 21464078
BMJ Open. 2014 Jun 24;4(6):e004798
pubmed: 24961715
Pain Physician. 2012 Jul-Aug;15(4):327-32
pubmed: 22828686
Cephalalgia. 2013 Sep;33(12):1017-25
pubmed: 23588795
Headache. 2002 Nov-Dec;42(10):963-73
pubmed: 12453027
Lancet Neurol. 2015 Jan;14(1):65-80
pubmed: 25496898
J Sch Nurs. 2019 Apr;35(2):88-95
pubmed: 28982283
World J Gastroenterol. 2016 Sep 28;22(36):8149-60
pubmed: 27688656
Eur J Neurol. 2006 Apr;13(4):333-45
pubmed: 16643310
Headache. 2001 Sep;41(8):798-804
pubmed: 11576205
Neurol Res Int. 2014;2014:808126
pubmed: 25538854
J Headache Pain. 2017 Oct 13;18(1):105
pubmed: 29030731
Clin Rheumatol. 2013 Oct;32(10):1553-6
pubmed: 23743661
Neuroepidemiology. 2006;27(2):61-6
pubmed: 16847389
J Stroke Cerebrovasc Dis. 2010 Mar;19(2):92-103
pubmed: 20189084